Investing.com - Financial Markets Worldwide
🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Peru has 10 years grace on new pharma rules under TPP -minister

Published 2015-10-07, 11:06 a/m
© Reuters. Peru has 10 years grace on new pharma rules under TPP -minister

WASHINGTON, Oct 7 (Reuters) - A Pacific trade deal gives
Peru 10 years grace before it has to implement new legislation
giving five years of data exclusivity to the makers of
next-generation biologic drugs, Peruvian Trade and Tourism
Minister Magali Silva said.
Peru was among 12 countries which agreed a new regional
trade pact on Monday, the Trans-Pacific Partnership, which will
set minimum standards for protection of innovative new
medicines, governing how quickly low-cost alternatives can come
onto the market.
"They have given us a transition period of 10 years, so in
13 years we will have done legislation that protects data from
(clinical) trials for biologic drugs for five years," Silva told
local broadcaster RPP, in an interview posted on the trade
ministry's website late on Tuesday.
The deal means companies can keep data used to develop
biologic drugs under wraps for at least five years. Coupled with
a buffer period, companies will have a monopoly for about eight
years, short of the 12 years the United States had originally
pushed for.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.